Evgen Pharma's total assets for Q2 2024 were £3.13M, an increase of 2.38% from the previous quarter. GB:TCF total liabilities were £467.00K for the fiscal quarter, a -35.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.